Trial Details

RECRUITING
Basic Information
Clinical ID c1604
Identifier NCT04806620
Trial Title Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Post-Acute COVID-19 Syndrome|ME/CFS|Rheumatic Arthritis|Juvenile Rheumatoid Arthritis (JRA)|Psoriatic Arthritis (PsA)|Ankylosing Spondylitis (AS)|Autoimmune Encephalitis|Celiac Disease|Celiac Disease in Children|Chronic Lyme Disease|Post-treatment Lyme Disease Syndrome|Crohn's Disease|Dysautonomia|Anorexia Nervosa|Bulimia Nervosa|ARFID|Avoidant / Restrictive Food Intake Disorder|Ehlers Danlos Syndrome|Endometriosis|Fibromyalgia (FM)|Long COVID|Lupus|Migraines|Mast Cell Activation Syndrome|Multiple Sclerosis|Myalgic Encephalomyelitis (ME)|Myasthenia Gravis, Generalized|Myasthenia Gravis in Children|Narcolepsy|Obsessive Compulsive Disorder (OCD)|PANDAS|Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)|POTS - Postural Orthostatic Tachycardia Syndrome|General Anxiety Disorder, Social Anxiety Disorder|PTSD - Post Traumatic Stress Disorder|Psoriasis|Traumatic Brain Injury|Tourette's Syndrome|Inflammatory Bowel Disease (IBD)|Autoimmune Diseases|Neurological Diseases or Conditions|Psychiatric Disorder|Sjogren's Syndrome|Ulcerative Colitis and Crohn's Disease
Interventions -
Participant Information
Sponsor Brain Inflammation Collaborative
City Delafield
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2023-07-05
Primary Completion Date 2030-06-30
Completion Date 2030-12-31